Li-Jiuan Shen

Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells

Y. Yen, Yun-Ru Chen, H. Forman, 2014, Science Signaling.

Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers.

Li-Jiuan Shen, W. Shen, 2006, Current opinion in molecular therapeutics.

Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.

Li-Jiuan Shen, W. Shen, K. Beloussow, 2006, Cancer letters.

Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.

Yun-Ru Chen, Li-Jiuan Shen, D. Ann, 2016, Molecular pharmaceutics.

Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells.

Li-Jiuan Shen, D. Ann, T. Terasaki, 2003, Biochemical pharmacology.

Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.

Li-Jiuan Shen, W. Shen, K. Beloussow, 2005, Biochemical pharmacology.

Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase.

Li-Jiuan Shen, Wen‐Chun Lin, W. Shen, 2003, Cancer letters.